Home
Magna Scientia Advanced Biology and Pharmacy
Peer-Reviewed • ISSN: 2582-8363 • Fast-Track Publishing • Impact Factor 8.6 • Low Publication Charges • Crossref DOI Linking

Main navigation

  • Home
    • Journal Information
    • Editorial Board Members
    • Abstracting and Indexing
    • Journal Policies
    • Our CrossMark Policy
    • Publication Ethics
    • Issue in Progress
    • Current Issue
    • Past Issues
    • Instructions for Authors
    • Article processing fee
    • Track Manuscript Status
    • Get Publication Certificate
    • Join Editorial Board
    • Join Reviewer Panel
  • Contact us
  • Downloads

Research and review articles are invited for publication in September - October 2026 (Volume 19, Issue 1) Submit manuscript

Multimodal deep learning models combining clinical imaging, vital-sign patterns, and workflow disruptions for early HAI detection

Breadcrumb

  • Home
  • Multimodal deep learning models combining clinical imaging, vital-sign patterns, and workflow disruptions for early HAI detection

Deborah Uzor *

Masters in Public Health, USA.
 
Research Article
Magna Scientia Advanced Biology and Pharmacy, 2023, 10(02), 131-147
Article DOI: 10.30574/msabp.2023.10.2.0081
DOI url: https://doi.org/10.30574/msabp.2023.10.2.0081
Received on 13 November 2023; revised on 27 December 2023; accepted on 30 December 2023
 
Healthcare-associated infections (HAIs) remain a persistent source of morbidity, mortality, and operational strain across global healthcare systems, underscoring the need for earlier, more accurate detection mechanisms. Traditional surveillance approaches often reliant on manual chart reviews, isolated clinical indicators, or retrospective laboratory results frequently fail to identify infection risks in real time. Recent advances in multimodal deep learning have created a pathway toward more proactive and context-aware HAI detection by integrating diverse, high-velocity data streams. From a broader perspective, multimodal architectures combine heterogeneous clinical inputs to form richer representations of patient status than single-modality models can achieve. Within this expanded analytical ecosystem, clinical imaging provides spatial and morphological patterns indicative of infection onset, enabling deep convolutional networks to detect infiltrates, device-associated abnormalities, or tissue inflammation earlier than human observers. Meanwhile, vital-sign trajectories such as temperature fluctuations, respiration irregularities, and hemodynamic variability offer temporal signals that recurrent or transformer-based models can interpret as precursors to infectious deterioration. These physiological streams capture dynamic physiological shifts that imaging alone may overlook. A third yet critical dimension involves workflow disruptions: delays in medication administration, unscheduled laboratory orders, extended device dwell times, or anomalous care-team interactions. These operational signals, often ignored in traditional surveillance, serve as proxies for latent safety hazards that correlate strongly with elevated HAI risk. Graph-based and sequence-fusion models can integrate these workflow anomalies with clinical modalities, generating holistic patient-risk scores that support earlier intervention. Narrowing the focus, this study emphasizes how multimodal deep learning pipelines that merge imaging features, vital-sign dynamics, and workflow irregularities can enhance predictive accuracy, reduce false alarms, and enable real-time infection prevention strategies. Such integrated frameworks represent a transformative advancement toward precision infection control and more resilient healthcare delivery systems.
 
Multimodal learning; Deep learning; HAI detection; Clinical imaging; Vital-sign analytics; Workflow disruptions
 
https://msabp.magnascientiapub.com/sites/default/files/fulltext_pdf/MSABP-2023-…

Preview Article PDF

Deborah Uzor. Multimodal deep learning models combining clinical imaging, vital-sign patterns, and workflow disruptions for early HAI detection. Magna Scientia Advanced Biology and Pharmacy, 2023, 10(2), 131-147. Article DOI: https://doi.org/10.30574/msabp.2023.10.2.0081

Copyright © Author(s). All rights reserved. This article is published under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, sharing, adaptation, distribution, and reproduction in any medium or format, as long as appropriate credit is given to the original author(s) and source, a link to the license is provided, and any changes made are indicated.


All statements, opinions, and data contained in this publication are solely those of the individual author(s) and contributor(s). The journal, editors, reviewers, and publisher disclaim any responsibility or liability for the content, including accuracy, completeness, or any consequences arising from its use.

Get Certificates

Get Publication Certificate

Download LoA

Check Corssref DOI details

Issue details

Issue Cover Page

Editorial Board

Table of content

Copyright © 2026 Magna Scientia Advanced Biology and Pharmacy - All rights reserved

Developed & Designed by VS Infosolution